Alcohol for Cognitive Effects
(REACT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how alcohol (also known as ethanol or ethyl alcohol) affects attention in young adults, both in a lab setting and in real life. Participants will perform attention tasks before and after consuming a standard amount of alcohol and will complete surveys over several weekends using an app. The researchers aim to determine if these tasks can effectively measure alcohol's effects on attention and whether these effects lead to risk-taking behavior. The trial suits individuals aged 21-25 who drink at least twice a week and have experienced at least one recent heavy drinking event, provided they have an iPhone and no medical issues related to alcohol. As an unphased trial, this study offers a unique opportunity to contribute to understanding alcohol's impact on attention and behavior.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you are on medications that are not safe to mix with alcohol, you may not be eligible to participate.
What prior data suggests that alcohol is safe for cognitive studies?
Research shows that alcohol can affect the brain and behavior in various ways. Studies indicate that about 33% to 50% of people with alcohol use problems experience noticeable issues with thinking or movement. This suggests alcohol might impact how some people think and move.
Other studies have found that excessive alcohol consumption can worsen memory and thinking skills, especially in men. For younger individuals, such as teens and college students, alcohol can harm the brain, leading to problems with memory, learning, or decision-making.
While this evidence demonstrates that alcohol can cause various thinking problems, the study under consideration will explore alcohol’s effects on attention in a controlled setting.12345Why are researchers excited about this trial?
Unlike standard cognitive enhancers that often rely on medications like cholinesterase inhibitors or NMDA receptor antagonists, the treatment under study uses alcohol, which is not traditionally associated with cognitive improvement. Researchers are curious about alcohol because it has a unique mechanism that can potentially affect neurotransmitter systems differently than existing drugs. This exploration could uncover new pathways for cognitive enhancement, offering insights that differ greatly from conventional treatments.
What evidence suggests that alcohol affects attention in young adults?
Research shows that alcohol consumption can affect brain function. Some studies suggest a link between small to moderate alcohol intake and better brain performance. However, excessive drinking can double the risk of serious memory problems. For instance, men who consumed about 36 grams of alcohol daily experienced faster memory decline over ten years. While light to moderate drinking is sometimes associated with improved thinking skills, these effects can vary greatly depending on the amount consumed. Participants in this trial will receive alcohol to study its cognitive effects.678910
Are You a Good Fit for This Trial?
This trial is for young adults interested in understanding how alcohol affects their attention. Participants will complete tasks before and after drinking a set amount of alcohol in a lab, and then on their phones over eight weekends.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Laboratory Session
Participants complete cognitive tasks before and after consuming alcohol to assess attention and risk-taking behaviors
Ecological Momentary Assessment (EMA)
Participants complete phone-based cognitive tasks and surveys over 8 weekends while wearing transdermal alcohol biosensors
Follow-up
Participants return to the lab for a follow-up session involving self-report questions and an interview
What Are the Treatments Tested in This Trial?
Interventions
- Alcohol
Alcohol is already approved in United States, European Union, Canada, Japan, China, Switzerland for the following indications:
- None (not approved as a therapeutic agent)
- None (not approved as a therapeutic agent)
- None (not approved as a therapeutic agent)
- None (not approved as a therapeutic agent)
- None (not approved as a therapeutic agent)
- None (not approved as a therapeutic agent)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Washington
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Collaborator